Clinical Outcomes
Engagement, patient experience and self reported outcomes in monitoring severe asthma
2023
NuvoAir spirometry FEV1 data predicts asthma exacerbations
2022
US COPD pilot shows patient reported reduction in hospitalizations and improved quality of life
2022
Study in Italy with virtual care for CF shows reduction in exacerbations
2022
Improvement in lung function and reduction in exacerbations in CF
2021
Improved attendance and reduced hospital admission rates for difficult to treat asthma
2021
Reduced booked and urgent face-to-face consultations in cystic fibrosis
2020
Engagement
Remote monitoring with personalized support for people with COPD results in high engagement
2023
High data quality and adherence in remote asthma diagnosis assessment program
2023
Weekly spirometry adherence and quality of spirometry sessions in ILD
2022
High adherence, reliability and concordance with hospital-based spirometry in Boston Children's Hospital study
2022
COPD members are highly engaged when supported by care coordinators in NuvoAir Virtual-First Care
2022
Data quality and adherence rates show promise for long-term monitoring of pediatric asthma
2021
Patient Experience
CF patients and clinicians report time savings with home spirometry
2022
CF patients report improved consultations with providers and understanding of their condition
2022
CF patients and clinicians in England-wide survey report high value and trust with NuvoAir to detect changes in lung function and monitor lung health
2021
High acceptability of NuvoAir home monitoring with pediatric asthma patients at Royal Brompton Hospital
2021
Successful home administration of biologics for pediatric severe asthma
2021
Swedish pilot shows technology can be used at home by children with CF with positive experience of virtual clinics
2020
Proven effective in driving CF virtual visits
2020
Patient experience with NuvoAir in CF post lung transplant
2020
Pilot study with Royal Brompton Hospital suggests NuvoAir may improve cystic fibrosis outcomes
2019
Data Quality
NuvoAir home spirometry suitable for children with CF
2022
Clinical effectiveness and validity of NuvoAir home spirometry in children with CF
2022
Real-world study shows Air Next comparable to office spirometry for children with asthma
2022
AstraZeneca real-world evidence study for a severe asthma treatment uses NuvoAir to monitor and assess lung function
2022
Boston Children's Hospital finds high reliability and good concordance to in-clinic testing with children with CF
2022
Unsupervised NuvoAir home spirometry with children produces high quality measurements
2022
Regeneron observational study uses NuvoAir to monitor effects of allergen exposure on asthma patients
2021
NuvoAir Cough app shows precision rate of 84% in detecting coughs
2021
Royal Brompton Hospital moves 558 CF patients to virtual care supported by NuvoAir
2021
Adults with severe asthma perform high quality unsupervised home spirometry with NuvoAir
2021
Reliable high quality spirometry measurements validate use for remote monitoring of asthma
2020
Unsupervised home spirometry is found equivalent to in-clinic spirometry
2020
NuvoAir unsupervised in-app coaching meets ATS/ERS repeatability criteria for pediatric CF and bronchiectasis patients
2020
Pediatric asthma and cystic fibrosis study validates NuvoAir spirometer against conventional spirometry
2020
Validation of Air Next spirometer with 200 patients across respiratory conditions
2020
200 patient study validates Air Next against Gold standard spirometry
2020
NuvoAir supports 10,000 Families Study for health assessment screening in Minnesota, U.S.
2020
Air Next supports Kazakhstan Academy of Preventive Medicine in assessing lung function changes in a COPD patient population
2020
200 patient study in South Africa validates NuvoAir spirometry
2019
NuvoAir technology supports 26 300 COPD patient study in Germany
2018
NuvoAir technology chosen for lung function monitoring in ALS study
2018
200 patient study at University Hospital Complex of Vigo, Spain validates NuvoAir spirometry technology
2018
